Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 32.60
0.00 (0.00%)
Oct 9, 2025, 2:59 PM CST
Locus Cell Revenue
Locus Cell had revenue of 1.73M TWD in the quarter ending June 30, 2025, with 657.46% growth. This brings the company's revenue in the last twelve months to 5.18M, up 397.69% year-over-year. In the year 2024, Locus Cell had annual revenue of 2.36M with 480.30% growth.
Revenue (ttm)
5.18M
Revenue Growth
+397.69%
P/S Ratio
1,259.66
Revenue / Employee
n/a
Employees
53
Market Cap
6.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.36M | 1.95M | 480.30% |
| Dec 31, 2023 | 406.00K | -194.00K | -32.33% |
| Dec 31, 2022 | 600.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |